Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Med Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced the ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...

--eMed, the market leader in at-home test verification technology and services, has named Michael Cole as Chief Financial Officer. "Welcoming Michael Cole to the eMed team signals an exciting time ...

The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...